FDA Approves Unknown Drug — CREEKWOOD PHARMS
Creekwood Pharmaceuticals announced today that the FDA has approved its Abbreviated New Drug Application (ANDA #219460), signaling the entry of the company into this therapeutic se…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Creekwood Pharmaceuticals announced today that the FDA has approved its Abbreviated New Drug Application (ANDA #219460), signaling the entry of the company into this therapeutic se…
MSN announced on August 14, 2026, that it has received final approval for ANDA 218873, opening the door to generic competition for the previously cited substance that will likely p…
Baxter Healthcare Corporation has secured FDA approval for intravenous sodium bicarbonate, a critical product for the acute management of metabolic acidosis. The approval bolsters …
Sandoz has received FDA approval for a line extension of its high-titer Emgality biosimilar, a 40 mg/administration formulation set to enter the Alpha sector of the migraine market…
E.R. Squibb & Sons, L.L.C. received FDA approval for Iberdomide Hydrochloride, a novel oral lenalidomide analog, suggesting a potential for significant expansion of Squibb's market…
**VIWIT PHARM** announced U.S. approval for its ANDA application this week, marking a significant step toward market entry. This regulatory clearance is poised to offer widespread …
NEW YORK, Aug 10 (Reuters) -- Aurobindo Pharma has secured approval from U.S. regulators for its generic version of the antiepileptic drug brivaracetam as the company continues to …
**FDA Approval News** On August 7, 2026, Aurobindo Pharma Limited received approval from the U.S. Food and Drug Administration (FDA) to market the generic version of Vancomycin Hy…
Merck Receives FDA Approval For Supplemental Biologics License Application For ENFLONSIA To Expand Indication To Prevention Of Respiratory Syncytial Virus Lower Respiratory Tract D…
Baxter Healthcare Corporation secured FDA approval on August 6, 2026, for Levetiracetam in the IV formulation as part of ANDA208458, a pivotal move that will likely intensify compe…
DR REDDYS received FDA approval for an ANDA application, which could enable a cost-effective entry into the market. This authorization signals potential expansion into a new therap…
Investors should look to take or hold Takeda Pharmaceuticals USA (NDA220860) shares as the regulatory body granted approval for this new treatment, setting the stage for the drug's…
Umedica Laboratories USA Inc. has received final FDA approval for sacubitril and valsartan under ANDA219946, allowing the company to enter the market for this blockbuster hypertens…
Macleods Pharmaceuticals has received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA219926) for oral nintedanib esylate, facilitating market entry for th…
Zydus Lifesciences Limited announced on Wednesday the approval of its Indocyanine Green generic application, expanding its portfolio of ophthalmic diagnostic agents. This regulator…
DR REDDYS LABS SA announced Friday the FDA approval of its undisclosed commercial drug application, with the pivotal regulatory milestone set to significantly impact the company’s …
Gland Pharma Limited has received FDA approval for its Atropine Sulfate ophthalmic product, issuing new competition for the branded segment. Patients may soon benefit from a more f…
KLM LABS PVT announced today that the FDA has approved its ANDA220017 for the targeted substance, marking a potential expansion of its product portfolio. The clearance is expected …
Johnson & Johnson Says FDA Grants Priority Review To Subcutaneous Amivantamab For Recurrent Or Metastatic Head And Neck Cancer, Citing 42% Overall Response Rate In OrigAMI-4 Study
DR REDDYS has received FDA approval for the new drug application ANDA220413, a timing that highlights the firm’s consistent manufacturing success despite current market volatility.…